Disseminate and recurrent infundibulofolliculitis: response to psoralen plus UVA therapy. 1999

B C Ravikumar, and C Balachandran, and S D Shenoi, and L Sabitha, and K Ramnarayan

UI MeSH Term Description Entries
D008730 Methoxsalen A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation. 8-Methoxypsoralen,Ammoidin,Xanthotoxin,8-MOP,Deltasoralen,Dermox,Geroxalen,Meladinina,Meladinine,Meloxine,Methoxa-Dome,Méladinine,Oxsoralen,Oxsoralen-Ultra,Puvalen,Ultramop,8 MOP,8 Methoxypsoralen,8MOP,Methoxa Dome,Oxsoralen Ultra
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005260 Female Females
D005499 Folliculitis Inflammation of follicles, primarily hair follicles. Sycosis,Folliculitides,Sycoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014467 Ultraviolet Therapy The use of ultraviolet electromagnetic radiation in the treatment of disease, usually of the skin. This is the part of the sun's spectrum that causes sunburn and tanning. Ultraviolet A, used in PUVA, is closer to visible light and less damaging than Ultraviolet B, which is ionizing. Actinotherapy,Therapy, Ultraviolet,Actinotherapies,Therapies, Ultraviolet,Ultraviolet Therapies
D017319 Photosensitizing Agents Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. Photosensitizer,Photosensitizers,Photosensitizing Agent,Photosensitizing Effect,Photosensitizing Effects,Agent, Photosensitizing,Agents, Photosensitizing,Effect, Photosensitizing,Effects, Photosensitizing

Related Publications

B C Ravikumar, and C Balachandran, and S D Shenoi, and L Sabitha, and K Ramnarayan
January 2004, Journal of drugs in dermatology : JDD,
B C Ravikumar, and C Balachandran, and S D Shenoi, and L Sabitha, and K Ramnarayan
February 1979, Archives of dermatology,
B C Ravikumar, and C Balachandran, and S D Shenoi, and L Sabitha, and K Ramnarayan
January 2019, Indian journal of dermatology,
B C Ravikumar, and C Balachandran, and S D Shenoi, and L Sabitha, and K Ramnarayan
January 2015, Pediatric dermatology,
B C Ravikumar, and C Balachandran, and S D Shenoi, and L Sabitha, and K Ramnarayan
December 2021, Journal of drugs in dermatology : JDD,
B C Ravikumar, and C Balachandran, and S D Shenoi, and L Sabitha, and K Ramnarayan
November 2008, Dermatology online journal,
B C Ravikumar, and C Balachandran, and S D Shenoi, and L Sabitha, and K Ramnarayan
November 2002, Cutis,
B C Ravikumar, and C Balachandran, and S D Shenoi, and L Sabitha, and K Ramnarayan
November 2020, The Australasian journal of dermatology,
B C Ravikumar, and C Balachandran, and S D Shenoi, and L Sabitha, and K Ramnarayan
January 2021, Proceedings (Baylor University. Medical Center),
B C Ravikumar, and C Balachandran, and S D Shenoi, and L Sabitha, and K Ramnarayan
September 1996, American journal of contact dermatitis : official journal of the American Contact Dermatitis Society,
Copied contents to your clipboard!